Ketamine Treatment for Antidepressant-Resistant PTSD
Study in Connecticut & Texas evaluates the medication with military & veterans
Are you a military service member or veteran whose PTSD symptoms did not improve after you took an antidepressant medication? Are you looking for a novel and promising new treatment approach?
The Consortium to Alleviate PTSD is conducting a clinical research study testing the anesthetic medication ketamine as a treatment for PTSD in military service members and veterans. Previous studies already have found ketamine to be effective with treatment-resistant depression. Now this study seeks to determine whether repeated doses of ketamine can effectively reduce symptoms of PTSD.
The study offers treatment without charge and is being conducted in West Haven, CT, in collaboration with the Department of Veterans Affairs’ National Center for PTSD, and in San Antonio, TX, in collaboration with Brooke Army Medical Center. Study participants will be randomly assigned to receive one of three treatments: (1) placebo/inactive medication; (2) low-dose ketamine; or (3) high dose-ketamine. All study participants who do not experience significant clinical improvement in PTSD symptoms at the end of the 4-week trial will be given the option of receiving a single dose of ketamine.
Are you a service member or veteran who has previously received medication treatment for PTSD? And are you still experiencing any of these symptoms?
| --Feeling jumpy or always on edge | --Loss of interest in regular activities |
| --Upsetting or distressing memories, nightmares, or flashbacks | --Mood swings or irritability |
| --Desire to avoid trauma reminders | --Sleep difficulties |
If so, this may be a great option for you. Contact us to learn more about this and our other ongoing programs.
Call 210-562-6726 or enter your information below and we will contact you within one business day.
GET MORE INFO:
